We are live on ! Find out more
GMAB icon

Genmab
GMAB

97 hedge funds and large institutions have $511M invested in Genmab in 2019 Q3 according to their latest regulatory filings, with 97 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38.78% more ownership

Funds ownership: 0% → 38.78% (+39%)

Holders
97
Holders Change
+97
Holders Change %
–
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
97
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
+$75.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$62M
3
Lazard Asset Management
Lazard Asset Management
New York
+$33.4M
4
BlackRock
BlackRock
New York
+$29.9M
5
HA
HHLR Advisors
Cayman Islands
+$29.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Artisan Partners
1
Artisan Partners
Wisconsin
$77.9M +$75.8M +3,846,111 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$63.8M +$62M +3,150,246 New
Lazard Asset Management
3
Lazard Asset Management
New York
$34.3M +$33.4M +1,694,121 New
BlackRock
4
BlackRock
New York
$30.8M +$29.9M +1,518,355 New
HA
5
HHLR Advisors
Cayman Islands
$30.4M +$29.5M +1,500,000 New
RG
6
Redmile Group
California
$25.3M +$24.6M +1,248,600 New
Citadel Advisors
7
Citadel Advisors
Florida
$23.4M +$22.8M +1,156,820 New
Federated Hermes
8
Federated Hermes
Pennsylvania
$19.9M +$19.3M +980,541 New
Wells Fargo
9
Wells Fargo
California
$19.1M +$18.5M +941,069 New
Bank of America
10
Bank of America
North Carolina
$18.9M +$18.4M +931,881 New
ZP
11
Zimmer Partners
New York
$15.2M +$14.8M +750,000 New
TIP
12
Torray Investment Partners
Maryland
$14.2M +$13.8M +699,340 New
HM
13
HealthCor Management
New York
$14.1M +$13.7M +696,835 New
Viking Global Investors
14
Viking Global Investors
Connecticut
$12M +$11.7M +592,966 New
PPA
15
Parametric Portfolio Associates
Washington
$8.6M +$8.36M +424,473 New
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$8.6M +$8.36M +424,217 New
SIG
17
Senator Investment Group
New York
$6.58M +$6.4M +325,000 New
Millennium Management
18
Millennium Management
New York
$6.33M +$6.15M +312,355 New
Natixis Advisors
19
Natixis Advisors
Massachusetts
$5.65M +$5.49M +278,931 New
SSA
20
Schonfeld Strategic Advisors
New York
$5.35M +$5.2M +264,045 New
UBS AM
21
UBS AM
Illinois
$4.9M +$4.76M +241,703 New
OAM
22
Oppenheimer Asset Management
New York
$4.79M +$4.65M +236,303 New
FAM
23
Fred Alger Management
New York
$4.68M +$4.55M +231,133 New
AG
24
Aperio Group
California
$4.28M +$4.16M +211,272 New
OMC
25
Old Mission Capital
Illinois
$4.22M +$4.1M +208,363 New
1
2 3 4

GMAB Hedge Fund Activity: Q3 2019 in Review

97 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2019, worth a combined $511M.

Buyers outnumbered sellers: 97 funds opened new GMAB positions and 0 closed out — a net gain of 97 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Artisan Partners, opening a new position worth an estimated $75.8M.

  • 97 institutional investors held Genmab (GMAB) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $511M of Genmab stock for Q3 2019.
  • 97 funds opened new Genmab positions in Q3 2019 and 0 closed out, a net change of +97 holders.
  • The largest Genmab buyer in Q3 2019 was Artisan Partners, an estimated $75.8M added.

Based on aggregated 13F filings for Q3 2019.